Glioblastoma cell line-derived spheres in serum-containing medium versus serum-free medium: A comparison of cancer stem cell properties

International Journal of Oncology

Volumn 41, Issue 5, 2012, Pages 1693-1700

  Hong, Xin ^a   Chedid, Khalil ^b   Kalkanis, Steven N ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer stem cells; Cell line; Differentiation; Glioblastoma; Sphere culture

Indexed keywords

HERMES ANTIGEN; NESTIN; TEMOZOLOMIDE; TRANSCRIPTION FACTOR SOX2;

ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CANCER STEM CELL; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; GLIOBLASTOMA; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; DACARBAZINE; GLIOBLASTOMA; HUMANS; INTERMEDIATE FILAMENT PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84867800145     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1592     Document Type: Article

References (37)

1. Qiao B, Johnson NW, Chen X, Li R, Tao Q and Gao J: Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Oncol Rep 26: 455-461, 2011.
2. Dalerba P, Cho RW and Clarke MF: Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284, 2007. (Pubitemid 46706514)
3. Venere M, Fine HA, Dirks PB and Rich JN: Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia 59: 1148-1154, 2011.
4. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001. (Pubitemid 33041634)
5. Marques DS, Sandrini JZ, Boyle RT, Marins LF and Trindade GS: Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Leuk Res 34: 757-762, 2010.
6. Storci G, Sansone P, Mari S, et al: TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 225: 682-691, 2010.
7. Yip NC, Fombon IS, Liu P, et al: Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer 104: 1564-1574, 2011.
8. Lapidot T, Sirard C, Vormoor J, et al: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648, 1994. (Pubitemid 24067706)
9. Galli R, Binda E, Orfanelli U, et al: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004. (Pubitemid 39331011)
10. Singh SK, Clarke ID, Hide T and Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273, 2004. (Pubitemid 39382160)
11. Leis O, Eguiara A, Lopez-Arribillaga E, et al: Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365, 2012.
12. Miki J and Rhim JS: Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic Dis 11: 32-39, 2008. (Pubitemid 351250327)
13. + population in hepatocellular carcinoma. Int J Cancer 126: 2067-2078, 2010.
14. Wang T, Ong CW, Shi J, et al: Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer 105: 658-665, 2011.
15. Hwang-Verslues WW, Kuo WH, Chang PH, et al: Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 4: e8377, 2009.
16. Salcido CD, Larochelle A, Taylor BJ, Dunbar CE and Varticovski L: Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer 102: 1636-1644, 2010.
17. Fillmore CM and Kuperwasser C: Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25, 2008.
18. +cells. J Stem Cells 5: 75-81, 2010.
19. Strojnik T, Rosland GV, Sakariassen PO, Kavalar R and Lah T: Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68: 133-144, 2007.
20. Uchida N, Buck DW, He D, et al: Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97: 14720-14725, 2000. (Pubitemid 32016642)
21. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004. (Pubitemid 39551674)
22. Ying M, Wang S, Sang Y, et al: Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene 30: 3454-3467, 2011.
23. Luk SU, Lee TK, Liu J, et al: Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One 6: e19804, 2011.
24. Shi MF, Jiao J, Lu WG, et al: Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell Mol Life Sci 67: 3915-3925, 2010.
25. Chandrasekaran S and DeLouise LA: Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line. Biomaterials 32: 9316-9327, 2011.
26. Fan X, Ouyang N, Teng H and Yao H: Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Int J Colorectal Dis 26: 1279-1285, 2011.
27. Zou J, Yu XF, Bao ZJ and Dong J: Proteome of human colon cancer stem cells: a comparative analysis. World J Gastroenterol 17: 1276-1285, 2011.
28. Zheng X, Shen G, Yang X and Liu W: Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 67: 3691-3697, 2007. (Pubitemid 46762154)
29. Qiang L, Yang Y, Ma YJ, et al: Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 279: 13-21, 2009.
30. Li A, Walling J, Kotliarov Y, et al: Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol Cancer Res 6: 21-30, 2008. (Pubitemid 351378163)
31. deCarvalho AC, Nelson K, Lemke N, et al: Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells 28: 181-190, 2010.
32. Weissman IL, Anderson DJ and Gage F: Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 17: 387-403, 2001. (Pubitemid 33096181)
33. Wu Y and Wu PY: CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 18: 1127-1134, 2009.
34. Clevers H: The cancer stem cell: premises, promises and challenges. Nat Med 17: 313-319, 2011.
35. Okamoto R, Takano H, Okamura T, et al: O(6)-methylguanine- DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives. Jpn J Cancer Res 93: 93-102, 2002. (Pubitemid 34144717)
36. Lee JS, Gil JE, Kim JH, et al: Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras. Biochem Biophys Res Commun 365: 496-502, 2008.
37. Moon JH, Kwon S, Jun EK, et al: Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. Biochem Biophys Res Commun 412: 175-181, 2011.